Tariffs could hit labs
- The UK House of Commons Library published a briefing explaining the U.S. 'reciprocal tariffs' policy and its goals. - The explainer notes tariffs target market access and trade imbalances, which could raise imported medical-supply costs. - For laboratories, persistent tariffs could mean higher consumable prices, delayed parts, and pressure on upgrade budgets (commonslibrary.parliament.uk).
A new UK Parliament briefing says U.S. tariffs now reach most UK goods, extending a trade fight that could raise costs inside laboratories. (commonslibrary.parliament.uk) The House of Commons Library published the briefing on April 14, 2026. It says President Donald Trump has imposed wide-ranging tariffs since taking office on January 20, 2025, and that a 10% tariff applies to most other UK goods entering the U.S. (commonslibrary.parliament.uk) The White House says the policy is meant to answer what it calls “non-reciprocal” trade, including foreign tariffs, taxes, subsidies, regulatory barriers and exchange-rate policies. An April 2, 2025 executive order tied the tariffs to “large and persistent” U.S. goods trade deficits and declared a national emergency. (whitehouse.gov 1) (whitehouse.gov 2) Tariffs are taxes paid by the importing business in the country that applies them, the Commons Library says. For labs, that means the extra cost lands first on distributors, hospitals, universities and testing companies buying imported instruments, plastics, reagents or replacement parts. (commonslibrary.parliament.uk) The UK-U.S. Economic Prosperity Deal announced on May 8, 2025 softened some pressure, but only in selected sectors. The Commons Library says pharmaceuticals can now enter the U.S. tariff-free, while steel and aluminium relief and possible semiconductor exemptions remain conditional or incomplete. (commonslibrary.parliament.uk) That leaves many lab-adjacent products exposed if they are not covered by a carveout. Lab Manager reported in March 2026 that higher duties on imported plastics, reagents, personal protective equipment and other supplies were already pushing up procurement costs, cost per test and purchasing forecasts. (labmanager.com) The same trade pressure shows up in capital equipment. Lab Manager reported in November 2025 that labs were seeing equipment quotes expire faster, consumable prices rise and lead times stretch as tariff costs and supply-chain strain worked through budgets. (labmanager.com) Medical-technology groups have been pressing for exemptions. On April 7, 2025, AdvaMed and nine other organizations asked U.S. Trade Representative Jamieson Greer to exempt medical and dental supplies, equipment and devices, saying tariffs could disrupt supply chains and raise costs for providers and hospitals. (advamed.org) AdvaMed says U.S.-made products account for about two-thirds of the country’s $250 billion medical-technology market, with the remaining third imported mainly from Europe and North America. Its tariff brief says many products use hundreds of components, and changing suppliers can require new Food and Drug Administration review, slowing any attempt to reroute sourcing. (advamed.org) For labs, the practical risk is not one dramatic shutdown but a steady squeeze: pricier test consumables, slower repairs, and delayed instrument upgrades. The Commons Library says the legal basis for several U.S. tariffs changed after a U.S. Supreme Court decision on February 20, 2026, and whether the 10% baseline stays in place remains unclear. (commonslibrary.parliament.uk)
